The challenge of cross-trial comparisons using limited data

Haematologica. 2014 Aug;99(8):e145-6. doi: 10.3324/haematol.2013.103135.

Authors

Jacob P Laubach¹, Edward A Faber Jr², Peter Voorhees³, Javid Moslehi⁴, Cindy Varga¹, Liviu Niculescu⁵, Kenneth C Anderson¹, Paul G Richardson⁶

Affiliations

¹ Dana-Farber Cancer Institute, Boston, MA, USA.
² Oncology / Hematology Care, Cincinnati, OH, USA.
³ Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
⁴ Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, MA, USA.
⁵ Millennium: The Takeda Oncology Company, Cambridge, MA, USA.
⁶ Dana-Farber Cancer Institute, Boston, MA, USA paul_richardson@dfci.harvard.edu.

No abstract available

Keywords: challenge; cross-trial; data.

Publication types

Letter
Comment

MeSH terms

Female
Humans
Male
Multiple Myeloma / drug therapy*
Oligopeptides / administration & dosage*
Oligopeptides / adverse effects*
Proteasome Inhibitors / administration & dosage*
Proteasome Inhibitors / adverse effects*

Substances

Oligopeptides
Proteasome Inhibitors